74 related articles for article (PubMed ID: 27434147)
1. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections.
Jentschke M; Chen K; Arbyn M; Hertel B; Noskowicz M; Soergel P; Hillemanns P
J Clin Virol; 2016 Sep; 82():46-50. PubMed ID: 27434147
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the performance of Human Papillomavirus testing in paired urine and clinician-collected cervical samples among women aged over 30 years in Bhutan.
Tshomo U; Franceschi S; Tshokey T; Tobgay T; Baussano I; Tenet V; Snijders PJ; Gheit T; Tommasino M; Vorsters A; Clifford GM
Virol J; 2017 Apr; 14(1):74. PubMed ID: 28390433
[TBL] [Abstract][Full Text] [Related]
3. Self-sampling for human papillomavirus DNA detection: a preliminary study of compliance and feasibility in BOLIVIA.
Surriabre P; Allende G; Prado M; Cáceres L; Bellot D; Torrico A; Ustariz K; Rojas S; Barriga J; Calle P; Villarroel L; Yañez RM; Baay M; Rodriguez P; Fontaine V
BMC Womens Health; 2017 Dec; 17(1):135. PubMed ID: 29273032
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal Swabs.
Qi M; Naranjo AR; Duque AJ; Lorey TS; Schapiro JM; Suh-Burgmann BJ; Rummel M; Salipante SJ; Wentzensen N; Greene DN
J Mol Diagn; 2024 Jun; 26(6):487-497. PubMed ID: 38494078
[TBL] [Abstract][Full Text] [Related]
5. Validation of the clinical performance and reproducibility of the NeuMoDx HPV assay self-sample workflow.
Heideman DAM; Berkhof J; Verhoef L; Ouwerkerk C; Smit PW; Oštrbenk Valenčak A; Mlakar J; Poljak M; Steenbergen RDM; Bleeker MCG
J Clin Virol; 2024 Apr; 171():105649. PubMed ID: 38335717
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two self-sampling methods for human papillomavirus (HPV) DNA testing among women with high prevalence rates.
Kuriakose S; Sabeena S; Damodaran B; Ravishankar N; Ramachandran A; Ameen N
J Med Virol; 2020 Dec; 92(12):3884-3888. PubMed ID: 32436997
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer prevention: Feasibility of self-sampling and HPV testing in rural and urban areas of Bolivia: An observational study.
Carozzi FM; Royder Yanez R; Paganini I; Sani C; Cannistrà S; Matucci M; von Borries S; Traina S
PLoS One; 2024; 19(3):e0292605. PubMed ID: 38451956
[TBL] [Abstract][Full Text] [Related]
8. Urine high-risk human papillomavirus testing as an alternative to routine cervical screening: A comparative diagnostic accuracy study of two urine collection devices using a randomised study design trial.
Davies JC; Sargent A; Pinggera E; Carter S; Gilham C; Sasieni P; Crosbie EJ
BJOG; 2024 Apr; ():. PubMed ID: 38660737
[TBL] [Abstract][Full Text] [Related]
9. Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage.
Desai KT; Ajenifuja KO; Banjo A; Adepiti CA; Novetsky A; Sebag C; Einstein MH; Oyinloye T; Litwin TR; Horning M; Olanrewaju FO; Oripelaye MM; Afolabi E; Odujoko OO; Castle PE; Antani S; Wilson B; Hu L; Mehanian C; Demarco M; Gage JC; Xue Z; Long LR; Cheung L; Egemen D; Wentzensen N; Schiffman M
Infect Agent Cancer; 2020; 15():60. PubMed ID: 33072178
[TBL] [Abstract][Full Text] [Related]
10. Agreement between Self- and Physician‑Sampling for Detection of High‑Risk Human Papillomavirus Infections in Women Attending Cervical Screening at National Cancer Institute, Thailand.
Sangrajrang S; Pitakkarnkul S; Muwonge R; Ploysawang P; Pangmuang P; Seeda K; Basu P
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2615-2619. PubMed ID: 37642046
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Opt-In Vaginal Human Papillomavirus Self-Sampling: Participation Rates and Detection of High-Grade Lesions (CIN2+) among Unscreened Japanese Women Aged 30-39.
Taro I; Onuma T; Kurokawa T; Chino Y; Shinagawa A; Yoshida Y
Healthcare (Basel); 2024 Mar; 12(5):. PubMed ID: 38470710
[TBL] [Abstract][Full Text] [Related]
12. Performance of a vaginal self-collection device versus clinician collected cervical samples for the detection of high-risk human papillomavirus.
Lopez Castro R; Escudero Rivas R; Ángeles Calderón M; Iglesias Linares L; Dolores Hurtado González M; Méndez Gómez N; de la Rosa Martos B; Esther Hidalgo Carmona M; Luis López Hidalgo J
Prev Med Rep; 2024 May; 41():102705. PubMed ID: 38595732
[TBL] [Abstract][Full Text] [Related]
13. Menstrual Blood as a Diagnostic Specimen for Human Papillomavirus Genotyping and Genital Tract Infection Using Next-Generation Sequencing as a Novel Diagnostic Tool.
Tsang HF; Cheung YS; Yu CA; Chan CS; Wong CT; Yim KA; Pei X; Wong SC
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611599
[TBL] [Abstract][Full Text] [Related]
14. Application of CytoPath®Easy Vials in Cervical Cancer Screening: Self-Sampling Approach.
Fernandes SPM; Vilarinho AS; Frutuoso A; Teixeira C; Silva RAAP
J Cytol; 2024; 41(2):67-74. PubMed ID: 38779609
[TBL] [Abstract][Full Text] [Related]
15. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
El-Zein M; Bouten S; Louvanto K; Gilbert L; Gotlieb W; Hemmings R; Behr MA; Franco EL;
Gynecol Oncol; 2018 Jun; 149(3):491-497. PubMed ID: 29678360
[TBL] [Abstract][Full Text] [Related]
16. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
[TBL] [Abstract][Full Text] [Related]
17. Is self-sampling to test for high-risk papillomavirus an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia?
Andersson S; Belkić K; Mints M; Östensson E
PLoS One; 2018; 13(6):e0199038. PubMed ID: 29912903
[TBL] [Abstract][Full Text] [Related]
18. VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.
Arbyn M; Peeters E; Benoy I; Vanden Broeck D; Bogers J; De Sutter P; Donders G; Tjalma W; Weyers S; Cuschieri K; Poljak M; Bonde J; Cocuzza C; Zhao FH; Van Keer S; Vorsters A
J Clin Virol; 2018 Oct; 107():52-56. PubMed ID: 30195193
[TBL] [Abstract][Full Text] [Related]
19. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis.
Yeh PT; Kennedy CE; de Vuyst H; Narasimhan M
BMJ Glob Health; 2019; 4(3):e001351. PubMed ID: 31179035
[TBL] [Abstract][Full Text] [Related]
20. Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions.
Leinonen MK; Schee K; Jonassen CM; Lie AK; Nystrand CF; Rangberg A; Furre IE; Johansson MJ; Tropé A; Sjøborg KD; Castle PE; Nygård M
J Clin Virol; 2018; 99-100():22-30. PubMed ID: 29289814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
